BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
22.35
-1.37 (-5.78%)
At close: Nov 18, 2024, 4:00 PM
22.44
+0.09 (0.40%)
After-hours: Nov 18, 2024, 5:01 PM EST

BridgeBio Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Cash & Equivalents
266.32375.94376.69393.77356.08363.77
Upgrade
Short-Term Investments
-58.9595.23442.89251.01182.22
Upgrade
Cash & Short-Term Investments
266.32434.88471.92836.66607.09545.99
Upgrade
Cash Growth
-50.98%-7.85%-43.59%37.81%11.19%25.20%
Upgrade
Accounts Receivable
0.481.7517.0819.75--
Upgrade
Other Receivables
2.1----2.85
Upgrade
Receivables
2.581.7517.0819.75-2.85
Upgrade
Prepaid Expenses
28.8713.3121.9232.2735.5919.78
Upgrade
Restricted Cash
139.4116.6537.930.180.14-
Upgrade
Other Current Assets
7.411----
Upgrade
Total Current Assets
444.58477.59548.85888.86642.82568.62
Upgrade
Property, Plant & Equipment
15.1419.8425.2545.9736.835.63
Upgrade
Long-Term Investments
160.44----31.14
Upgrade
Other Intangible Assets
24.5326.3228.7144.93--
Upgrade
Other Long-Term Assets
20.2922.6320.2233.0323.9326.29
Upgrade
Total Assets
664.98546.38623.041,013703.59631.68
Upgrade
Accounts Payable
13.3610.6611.5611.888.958.85
Upgrade
Accrued Expenses
104.7116.9795.54116.7571.947.46
Upgrade
Current Portion of Long-Term Debt
----1.46-
Upgrade
Current Portion of Leases
4.64.133.684.943.8-
Upgrade
Current Unearned Revenue
11.776.18.16---
Upgrade
Other Current Liabilities
4.7962.51.59.554.08
Upgrade
Total Current Liabilities
139.22143.84121.43135.0795.6560.39
Upgrade
Long-Term Debt
1,7191,7271,7081,704475.8691.79
Upgrade
Long-Term Leases
5.838.9812.2717.4314.68-
Upgrade
Long-Term Unearned Revenue
18.633.87.1---
Upgrade
Long-Term Deferred Tax Liabilities
----1.1-
Upgrade
Other Long-Term Liabilities
0.385.5619.5422.078.423.53
Upgrade
Total Liabilities
1,8831,8891,8681,878595.7155.7
Upgrade
Common Stock
0.20.180.160.150.130.12
Upgrade
Additional Paid-In Capital
1,8761,481938.7841.531,021848.11
Upgrade
Retained Earnings
-2,831-2,561-1,918-1,437-888.76-440.03
Upgrade
Treasury Stock
-275-275-275-275-75-
Upgrade
Comprehensive Income & Other
0.010.03-0.33-0.130.190.25
Upgrade
Total Common Equity
-1,230-1,354-1,255-870.4157.91408.45
Upgrade
Minority Interest
11.5311.729.694.8449.9867.52
Upgrade
Shareholders' Equity
-1,218-1,343-1,245-865.58107.89475.98
Upgrade
Total Liabilities & Equity
664.98546.38623.041,013703.59631.68
Upgrade
Total Debt
1,7301,7401,7241,726495.7991.79
Upgrade
Net Cash (Debt)
-1,463-1,305-1,252-889.51111.31485.35
Upgrade
Net Cash Growth
-----77.07%27.19%
Upgrade
Net Cash Per Share
-8.03-8.02-8.49-6.160.944.62
Upgrade
Filing Date Shares Outstanding
188.99175.83151.37147.61146.54123.77
Upgrade
Total Common Shares Outstanding
188.99175.08150.63147.34122.85123.66
Upgrade
Working Capital
305.36333.75427.43753.79547.18508.24
Upgrade
Book Value Per Share
-6.51-7.73-8.33-5.910.473.30
Upgrade
Tangible Book Value
-1,254-1,381-1,283-915.3557.91408.45
Upgrade
Tangible Book Value Per Share
-6.64-7.89-8.52-6.210.473.30
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.